Intelligent Investor

Polynovo Limited (ASX: PNV) - Announcements

Current share price for PNV : $2.090 0.08 (3.98%)

ASX company news and announcements for Polynovo Limited (PNV) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Polynovo Limited (PNV) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Polynovo Limited (PNV), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Polynovo Limited (PNV)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$1,443 Appendix 3Y - Andrew Lumsden 22 Feb 2023 8:07AM $2.310 $2.090 $1.990 fallen by 9.52%
$1,443 Appendix 3Y - Bruce Rathie 22 Feb 2023 8:07AM $2.310 $2.090 $1.990 fallen by 9.52%
$1,443 Appendix 3Y - David Williams 22 Feb 2023 8:05AM $2.310 $2.090 $1.990 fallen by 9.52%
$1,443 Cleansing Notice 16 Feb 2023 9:10AM $2.260 $2.090 $1.990 fallen by 7.52%
$1,443 Application for quotation of securities - PNV 15 Feb 2023 10:06AM $2.270 $2.090 $1.990 fallen by 7.93%
$1,443 Update - SynPath Diabetic Foot Ulcer Trial 15 Feb 2023 9:11AM $2.270 $2.090 $1.990 fallen by 7.93%
$1,443 Webcast details - 1HFY23 Results 14 Feb 2023 9:53AM $2.270 $2.090 $1.990 fallen by 7.93%
$1,443 Results of General Meeting 17 Jan 2023 12:17PM $2.445 $2.090 $1.990 fallen by 14.52%
$1,443 1H23 Indicative Trading Result (unaudited) 16 Jan 2023 9:17AM $2.540 $2.090 $1.990 fallen by 17.72%
$1,443 Presentation slides - J.P. Morgan Healthcare Conference 11 Jan 2023 4:20PM $2.440 $2.090 $1.990 fallen by 14.34%
$1,443 Presentation to J.P. Morgan Healthcare Conference 10 Jan 2023 5:09PM $2.500 $2.090 $1.990 fallen by 16.40%
$1,443 Application for quotation of securities - PNV 19 Dec 2022 10:20AM $2.020 $2.090 $1.990 risen by 3.47%
$1,443 Successful Completion of Share Purchase Plan 16 Dec 2022 1:49PM $2.050 $2.090 $1.990 risen by 1.95%
$1,443 Webcast Recording - Investor Presentation and Update 7 Dec 2022 8:34AM $1.940 $2.090 $1.990 risen by 7.73%
$1,443 Notice of General Meeting 7 Dec 2022 8:33AM $1.940 $2.090 $1.990 risen by 7.73%
$1,443 Webcast Agenda - Investor Presentation and Update 5 Dec 2022 10:54AM $1.970 $2.090 $1.990 risen by 6.09%
$1,443 Amended Weblink - Investor Presentation & Update 5 Dec 2022 2 Dec 2022 11:01AM $2.000 $2.090 $1.990 risen by 4.50%
$1,443 Investor Presentation & Update - Webcast 5 Dec 2022 2 Dec 2022 8:19AM $2.030 $2.090 $1.990 risen by 2.96%
$1,443 Share Purchase Plan (SPP) Offer 30 Nov 2022 8:22AM $1.940 $2.090 $1.990 risen by 7.73%
$1,443 Cleansing Notice 29 Nov 2022 8:25AM $1.915 $2.090 $1.990 risen by 9.14%
$1,443 Application for quotation of securities - PNV 28 Nov 2022 11:52AM $1.913 $2.090 $1.990 risen by 9.28%
$1,443 Ceasing to be a substantial holder 23 Nov 2022 7:13PM $1.905 $2.090 $1.990 risen by 9.71%
$1,443 Completion of $30m Institutional Placement 23 Nov 2022 8:57AM $2.090 $2.090 $1.990 fallen by 0%
$1,443 Proposed issue of securities - PNV 22 Nov 2022 12:21PM $2.090 $2.090 $1.990 fallen by 0%
$1,443 Investor Presentation 22 Nov 2022 12:19PM $2.090 $2.090 $1.990 fallen by 0%

51 - 75 of 500 results

Page 3 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.